retatrutide fda approval 2026 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide just took a major
Description
list prices for Ozempic and Wegovy by up to 50%, effective January 2027
**Tirzepatide (once weekly):** One subcutaneous injection per week

This combination is common in diabetes management, and the increased urination is an expected, intended therapeutic effect

If you live in Brooklyn or the surrounding area, now may be a good time to consider whether GLP-1 therapy could be appropriate

The FDA has warned people several times about the dangers of this
